ArticleBMC cancer2018

Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL).

Therasa Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.